The LC Pharma Fund will make multiple investments in the pharmaceutical industry while navigating the rapidly changing industry dynamics.
The essence of the idea is to invest into carefully chosen private targets along the pharmaceutical supply chain to increase return multiples without the limitations of an integrated approach.
The LC Pharma Fund’s investment focus is on the pharmaceutical industry i.e., on companies active in the discovery, development, and manufacture of drugs and medications (pharmaceuticals). The fund aims at building a portfolio of pharmaceutical companies to secure attractive returns for the investors.
A first investment was made into LC MED AG (www.lcmed.de), a company active in the production and sale of pharmaceuticals based on cannabis. LC MED AG is fully licensed to distribute its products across Germany. It has entered a strategic cooperation with the JuicyFields-Group, a leading player in the medical cannabis sector, to jointly develop the German market.